TRACON Pharmaceuticals, Inc.
TCON · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,839 | -$3,168 | $439 | $10,763 |
| Dep. & Amort. | $4 | $4 | $3 | $8 |
| Deferred Tax | $0 | $0 | $617 | $0 |
| Stock-Based Comp. | $339 | $383 | $490 | $493 |
| Change in WC | -$273 | $234 | -$1,458 | $3,119 |
| Other Non-Cash | $0 | $163 | -$613 | $669 |
| Operating Cash Flow | -$2,769 | -$2,543 | -$522 | $15,052 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$10,500 |
| Stock Issued | $1,147 | $1,870 | $1,322 | $1,409 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $2 | $0 |
| Financing Cash Flow | $1,148 | $1,870 | $1,324 | -$9,091 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,621 | -$673 | $801 | $5,961 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,964 | $8,564 | $7,763 | $1,874 |
| End Cash | $6,343 | $7,891 | $8,564 | $7,835 |
| Free Cash Flow | -$2,769 | -$2,543 | -$522 | $15,052 |